You have 10 free articles left this month. Get your freeBasic subscription now and gain instant access to more.

Bulgaria's Donev Investments Holding lifts stake in Sopharma

Author Mario Tanev
Bulgaria's Donev Investments Holding lifts stake in Sopharma Sopharma/ All rights reserved

SOFIA (Bulgaria), September 12 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday that its largest direct shareholder Donev Investments Holding has acquired 723 shares in the company at a weighted average price per share of 3.35 levs ($1.89/1.71 euro).

Donev Investments Holding acquired the shares through three deals on the Bulgarian Stock Exchange on September 11, Sopharma said in a bourse filing.

Earlier on Thursday, Sopharma said that its CEO Ognyan Donev has acquired 5,620 shares in the company at a weighted average price per share of 3.3571 levs on September 11. Donev, who controls Donev Investments Holding, has been actively acquiring small packages of Sopharma shares since the start of September. 

Donev Investments Holding held a 25.39% stake in Sopharma at the end of June.

Sopharma shares closed at a price of 3.39 levs on the Bulgarian Stock Exchange on Wednesday.

(1 euro = 1.95583 levs)